Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Disposal of unused meds
Norditropin NordiFlex® (somatropin [rDNA origin]) - product information

Norditropin NordiFlex® (somatropin [rDNA origin])

Overview | Product information | Accredo services | Contact team


Norditropin NordiFlex is available in pre-filled liquid cartridges.

The pre-filled formulation is administered with the NordiFlex pen device, which is the only pre-filled multi-dose disposable pen currently available.

Approved for the following diagnosis:

  • Growth hormone deficiency (GHD) in children and adults
  • Noonan syndrome
  • Turner syndrome
  • Small for gestational age (SGA)

For more information, please visit Norditropin-us.com, or download the full prescribing information.


Norditropin
NordiFlex is a registered trademark of Novo Nordisk A/S, Denmark.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us